Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans.
about
STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertaintiesDeciphering Human Cell-Autonomous Anti-HSV-1 Immunity in the Central Nervous SystemTLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetesCurrent aspects on the management of viral uveitis in immunocompetent individualsInnate immune interactions within the central nervous system modulate pathogenesis of viral infectionsCrystal ball - 2011The C terminus of the large tegument protein pUL36 contains multiple capsid binding sites that function differently during assembly and cell entry of herpes simplex virusAttenuation of the influenza virus sickness behavior in mice deficient in Toll-like receptor 3Toll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infectionEntry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infectionThe calcitonin receptor gene is a candidate for regulation of susceptibility to herpes simplex type 1 neuronal infection leading to encephalitis in ratMouse ENU Mutagenesis to Understand Immunity to Infection: Methods, Selected Examples, and Perspectives.Genome-wide mouse mutagenesis reveals CD45-mediated T cell function as critical in protective immunity to HSV-1.NEMO is a key component of NF-κB- and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus.dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity.Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity.C21orf91 genotypes correlate with herpes simplex labialis (cold sore) frequency: description of a cold sore susceptibility geneHerpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiencyFunctional genomics reveals an essential and specific role for Stat1 in protection of the central nervous system following herpes simplex virus corneal infectionIncreased Viral Dissemination in the Brain and Lethality in MCMV-Infected, Dicer-Deficient NeonatesInborn errors of anti-viral interferon immunity in humans.Von Willebrand Factor Gene Variants Associate with Herpes simplex Encephalitis.Laboratory evaluation of primary immunodeficienciesType I interferons: diversity of sources, production pathways and effects on immune responses.Cold sore susceptibility gene-1 genotypes affect the expression of herpes labialis in unrelated human subjects.Synergistic control of herpes simplex virus pathogenesis by IRF-3, and IRF-7 revealed through non-invasive bioluminescence imaging.The genetic theory of infectious diseases: a brief history and selected illustrations.Human genetics of infectious diseases: between proof of principle and paradigm.ICAM-5 modulates cytokine/chemokine production in the CNS during the course of herpes simplex virus type 1 infection.Rapid host immune response and viral dynamics in herpes simplex virus-2 infection.Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century.Addressing diagnostic challenges in primary immunodeficiencies: laboratory evaluation of Toll-like receptor- and NF-κB-mediated immune responses.Attack, parry and riposte: molecular fencing between the innate immune system and human herpesviruses.Use of in vivo imaging to monitor the progression of experimental mouse cytomegalovirus infection in neonates.Manipulating Glucose Metabolism during Different Stages of Viral Pathogenesis Can Have either Detrimental or Beneficial Effects.Early ''relapse'' after herpetic encephalitis: extensive white matter lesions in an infant with interferon production deficit.Differentiated Human SH-SY5Y Cells Provide a Reductionist Model of Herpes Simplex Virus 1 Neurotropism.Viral infection leading to brain dysfunction: more prevalent than appreciated?Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer.Herpes simplex encephalitis in patients with cancer.
P2860
Q26829298-3832317A-5331-4132-A7F0-300D9FB7507DQ26991623-54A18C4C-83AC-42AA-9D3E-7D8A90531DC7Q27025559-EE99C84F-CA8D-4542-99A0-8EB1622F60C0Q28082276-B757B1A9-B050-457F-A91B-6D2BF6C5D430Q28085294-7D3A1344-B345-4DC6-993F-3A0107B579C3Q28661746-47DADDEF-D6A8-4E3B-B515-AA8F17918770Q30424771-00FBF80C-B910-424F-93B6-34B2073CB951Q33637378-F1704535-9A27-4C82-BCC3-48A69516C7DFQ34254496-6C5E33B7-40AB-45EC-8175-59977C801D46Q34270399-86FF7E96-A2E8-4C43-B7D4-3AA9AAEAE18EQ34325500-1DC4C358-5841-4F47-A48A-562EFAAE56C1Q34774733-CE8FC758-5D0D-4F21-9A9F-F4CE013BB995Q34998251-727BB2DD-994F-428F-8C4A-806CF2A795E0Q35190204-38FC9CB1-4E5F-499A-B2F9-FB5584DB3060Q35205757-48CC81DD-A6FB-4726-93FD-24EA3EB1AD66Q35237500-B213A8BC-6C7D-420D-8551-71C7778F1772Q35463681-D3DB2977-487B-4A9E-B342-E464DEA2E5EEQ35578631-82CD36B6-8BC9-4A7D-AA91-24D78250DD70Q35599416-5F9A8CD6-E462-484E-A214-FB572BE0AEC3Q35675999-024CC39D-401B-4087-A69A-5E0942BB02F1Q35759651-D674B3E0-6CDE-47AD-BBD9-FCE6238196C1Q36029291-953BDD61-675D-452D-A6FE-8B4764F742E6Q36142583-ABA5A84F-2F1D-4255-853A-CEEB20208980Q36611339-2567CA8C-0A3B-4EE6-A35E-0743C3A9A7A7Q36671166-1E1CE9FA-B2FD-47EE-9A14-F20A4B51A8A4Q37126135-F465691A-814A-480E-9127-BB76AE8CFEA2Q37166962-A92A71E0-08F8-4B60-8001-8D99BC53AF02Q37328431-FE6539AB-183D-49A2-8745-DFEBFADB9BEAQ37360119-B269B650-9AE4-4BF3-821D-5DE396E50E60Q37694574-B5400EE6-8B3F-4887-8B0E-A8B7882B564DQ37962982-EB7592AA-D12F-44DA-9506-FE6021939765Q38188634-6666B885-2C9A-4B8C-AF13-F22E99444E47Q38523847-25AC3E51-2433-419C-BF0F-3B037420C5BDQ39385216-8B537AF5-8495-4523-B47B-62515E87D1A4Q40097679-A1EECCB9-8EA8-461B-AC9A-E012BB973120Q40339845-4E5CC6F8-32FD-40AA-8712-E72721BFBBD5Q41928819-2C7D8B3E-C721-4A64-B7CE-6C58E05BEDC3Q42153284-B9A33296-BB04-4389-AFE9-AD0128CEDF65Q42837601-34E5AD91-7A53-449A-8C38-FE3CFE8155B2Q44031298-FBCA6D26-5EB5-41D8-8FF7-CB441EC0B752
P2860
Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans.
@en
type
label
Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans.
@en
prefLabel
Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans.
@en
P2093
P50
P1476
Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans.
@en
P2093
Flore Rozenberg
Laurent Abel
Marc Tardieu
Vanessa Sancho-Shimizu
P304
P356
10.1097/ACI.0B013E3282F151D2
P577
2007-12-01T00:00:00Z